...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Constellation Pharma news, courtesy of rndtbl

Good find by rndtbl over on Investor Village.

Constellation Pharma up 152% on positive CPI-0610 data

https://seekingalpha.com/news/3515394-constellation-pharma-152-percent-positive-cpiminus-0610-data

This abstract to be presented at the December ASH meeting.

Zenith isn't in the myelofibrosis arena and Constellation isn't in the breast/prostate cancer arena. So no near term competition. Is Constellation the most advanced BET inhibitor rival to Zenith? Here's Constellation's recent Corporate Presentation.

BDAZ

Share
New Message
Please login to post a reply